Clínica Baviera, S.A. acquired Loiola Visión from Manuel Salaberría.
February 27, 2018
Share
Clínica Baviera, S.A. (BME:CBAV) acquired Loiola Visión from Manuel Salaberría in June 2017. Following the acquisition, Clínica Baviera integrated the three clinics of Loiola Visión located in San Sebastián, Azpeitia and Irún. Manuel Salaberría has joined the medical staff of Clínica Baviera and will head the retina division of Baviera in the northern region.
Clínica Baviera, S.A. (BME:CBAV) completed the acquisition of Loiola Visión from Manuel Salaberría in June 2017.
Clinica Baviera SA is a Spain-based company engaged in the healthcare sector. The Company focuses on providing services within the field of ophthalmic medicine. The Company is specialized in the diagnosis and treatment of eye disorders, including myopia, hyperopia, astigmatism, cataracts, glaucoma, vitreous-retina and strabismus, among others. The Company operates a network of clinics located in various European countries, such as Spain, Germany, Austria and Italy. In addition, the Company is a parent of the Baviera Group, a group that comprises a number of controlled entities, including Clinica Baviera Italia Srl, Clinica Baviera Mallorca SL, Care Vision Germany GmbH and Castellana de Intermediacion Sanitaria SL, among others. The main shareholder of the Company is Aier Eye International (Europe) Slu.